Bradykinin antagonist decreases early disruption of the blood-spinal cord barrier after spinal cord injury in mice

Neuroscience Letters

Volumn 307, Issue 1, 2001, Pages 25-28

  Pan, Weihong ^a,c   Kastin, Abba J ^a   Gera, Lajos ^b   Stewart, John M ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B9430; Blood brain barrier; Bradykinin; Cytokine; Transport system; Tumor necrosis factor

Indexed keywords

B 9430; BRADYKININ; BRADYKININ ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN INTERACTION; SPINAL CORD; SPINAL CORD INJURY; SPINAL ROOT; TISSUE INJURY;

ANIMALS; BLOOD-BRAIN BARRIER; BRADYKININ; CELL MEMBRANE PERMEABILITY; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED ICR; SPINAL CORD; SPINAL CORD INJURIES; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035816419     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01904-8     Document Type: Article

References (18)

1. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: Evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2 + accumulation
2. Transendothelial vesicular transport of protein following compression injury to the spinal cord
3. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
4. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
5. Ultrastructural blood-brain barrier alterations and edema formation in acute spinal cord trauma
6. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
7. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: Results of a multi-center, randomized, placebo-controlled trial
8. Neuroprotective signal transduction: Relevance to stroke
9. Traumatic brain contusions: A clinical role for the kinin antagonist CP-0127
10. BBB permeability to ebiratide and TNF in acute spinal cord injury
11. Permeability of the blood-brain and blood-spinal cord barriers to interferons
12. Differential permeability of the BBB in acute EAE: Enhanced transport of TNF-α
13. Upregulation of tumor necrosis factor α transport across the blood-brain barrier after acute compressive spinal cord injury
14. Tumor necrosis factor α: A neuromodulator in the CNS
15. Increase in TNFα transport after SCI is specific for time, region, and type of lesion
16. Tumor necrosis factor facilitates regeneration of injured central nervous system axons
17. Potent, long-acting bradykinin antagonists for a wide range of applications
18. Potent, wide-spectrum, orally active bradykinin antagonists